EGFR as a biomarker of smoking status and survival in oropharyngeal squamous cell carcinoma

Abstract Background This study aims to investigate EGFR as a prognostic biomarker in oropharyngeal squamous cell carcinoma (OPSCC). Methods OPSCC patients from retrospective (1998–2009) and prospective cohorts (2014–2017) were included. Retrospectively collected tumors were used to construct tissue...

Full description

Saved in:
Bibliographic Details
Main Authors: Shanmugappiriya Sivarajah, Morris Kostiuk, Cameron Lindsay, Lakshmi Puttagunta, Daniel A. O’Connell, Jeffrey Harris, Hadi Seikaly, Vincent L. Biron
Format: Article
Language:English
Published: SAGE Publishing 2019-01-01
Series:Journal of Otolaryngology - Head and Neck Surgery
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40463-018-0323-6
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832544115195117568
author Shanmugappiriya Sivarajah
Morris Kostiuk
Cameron Lindsay
Lakshmi Puttagunta
Daniel A. O’Connell
Jeffrey Harris
Hadi Seikaly
Vincent L. Biron
author_facet Shanmugappiriya Sivarajah
Morris Kostiuk
Cameron Lindsay
Lakshmi Puttagunta
Daniel A. O’Connell
Jeffrey Harris
Hadi Seikaly
Vincent L. Biron
author_sort Shanmugappiriya Sivarajah
collection DOAJ
description Abstract Background This study aims to investigate EGFR as a prognostic biomarker in oropharyngeal squamous cell carcinoma (OPSCC). Methods OPSCC patients from retrospective (1998–2009) and prospective cohorts (2014–2017) were included. Retrospectively collected tumors were used to construct tissue microarrays (TMAs), which were stained with EGFR, p16, DAPI and Pan-cytokeratin, and digitally quantified. EGFR, CDKN2A and HPV E6/7 levels from prospectively collected OPSCC was measured by droplet digital PCR (ddPCR). Biomarkers were compared to patient covariates, factors and survival outcomes. Results A total of 249 patients were included retrospectively and 64 patients were enrolled prospectively. p16 status (p < 0.001), smoking above 10 pack years (p = 0.04), smoking above 20 pack years (p < 0.001), total EGFR tumor levels (p = 0.016), and high EGFR within high or low Ki67 tumor nuclear staining (p = 0.03) were found to be significant predictors of 5-year disease specific survival (DSS). A Cox proportional hazard model of DSS showed smoking status and eGFR expression to be dependent of each other on predicting 5-year DSS. ddPCR analysis showed a significant association between smoking status and EGFR levels. Conclusions Total EGFR tumor levels are predictive of 5-year DSS. EGFR levels correlate with. smoking and could be an objective marker for this disease etiology.
format Article
id doaj-art-3c2dffc5747342128cfa0d496afe21e5
institution Kabale University
issn 1916-0216
language English
publishDate 2019-01-01
publisher SAGE Publishing
record_format Article
series Journal of Otolaryngology - Head and Neck Surgery
spelling doaj-art-3c2dffc5747342128cfa0d496afe21e52025-02-03T10:54:12ZengSAGE PublishingJournal of Otolaryngology - Head and Neck Surgery1916-02162019-01-014811810.1186/s40463-018-0323-6EGFR as a biomarker of smoking status and survival in oropharyngeal squamous cell carcinomaShanmugappiriya Sivarajah0Morris Kostiuk1Cameron Lindsay2Lakshmi Puttagunta3Daniel A. O’Connell4Jeffrey Harris5Hadi Seikaly6Vincent L. Biron7Division of Otolaryngology-Head & Neck Surgery, University of Alberta HospitalOtolaryngology-Head and Neck Research Laboratory of Alberta, University of AlbertaOtolaryngology-Head and Neck Research Laboratory of Alberta, University of AlbertaDepartment of Laboratory Medicine and Pathology, University of AlbertaDivision of Otolaryngology-Head & Neck Surgery, University of Alberta HospitalDivision of Otolaryngology-Head & Neck Surgery, University of Alberta HospitalDivision of Otolaryngology-Head & Neck Surgery, University of Alberta HospitalDivision of Otolaryngology-Head & Neck Surgery, University of Alberta HospitalAbstract Background This study aims to investigate EGFR as a prognostic biomarker in oropharyngeal squamous cell carcinoma (OPSCC). Methods OPSCC patients from retrospective (1998–2009) and prospective cohorts (2014–2017) were included. Retrospectively collected tumors were used to construct tissue microarrays (TMAs), which were stained with EGFR, p16, DAPI and Pan-cytokeratin, and digitally quantified. EGFR, CDKN2A and HPV E6/7 levels from prospectively collected OPSCC was measured by droplet digital PCR (ddPCR). Biomarkers were compared to patient covariates, factors and survival outcomes. Results A total of 249 patients were included retrospectively and 64 patients were enrolled prospectively. p16 status (p < 0.001), smoking above 10 pack years (p = 0.04), smoking above 20 pack years (p < 0.001), total EGFR tumor levels (p = 0.016), and high EGFR within high or low Ki67 tumor nuclear staining (p = 0.03) were found to be significant predictors of 5-year disease specific survival (DSS). A Cox proportional hazard model of DSS showed smoking status and eGFR expression to be dependent of each other on predicting 5-year DSS. ddPCR analysis showed a significant association between smoking status and EGFR levels. Conclusions Total EGFR tumor levels are predictive of 5-year DSS. EGFR levels correlate with. smoking and could be an objective marker for this disease etiology.http://link.springer.com/article/10.1186/s40463-018-0323-6Oropharyngeal cancerHPVSurvivalSmokingEGFR
spellingShingle Shanmugappiriya Sivarajah
Morris Kostiuk
Cameron Lindsay
Lakshmi Puttagunta
Daniel A. O’Connell
Jeffrey Harris
Hadi Seikaly
Vincent L. Biron
EGFR as a biomarker of smoking status and survival in oropharyngeal squamous cell carcinoma
Journal of Otolaryngology - Head and Neck Surgery
Oropharyngeal cancer
HPV
Survival
Smoking
EGFR
title EGFR as a biomarker of smoking status and survival in oropharyngeal squamous cell carcinoma
title_full EGFR as a biomarker of smoking status and survival in oropharyngeal squamous cell carcinoma
title_fullStr EGFR as a biomarker of smoking status and survival in oropharyngeal squamous cell carcinoma
title_full_unstemmed EGFR as a biomarker of smoking status and survival in oropharyngeal squamous cell carcinoma
title_short EGFR as a biomarker of smoking status and survival in oropharyngeal squamous cell carcinoma
title_sort egfr as a biomarker of smoking status and survival in oropharyngeal squamous cell carcinoma
topic Oropharyngeal cancer
HPV
Survival
Smoking
EGFR
url http://link.springer.com/article/10.1186/s40463-018-0323-6
work_keys_str_mv AT shanmugappiriyasivarajah egfrasabiomarkerofsmokingstatusandsurvivalinoropharyngealsquamouscellcarcinoma
AT morriskostiuk egfrasabiomarkerofsmokingstatusandsurvivalinoropharyngealsquamouscellcarcinoma
AT cameronlindsay egfrasabiomarkerofsmokingstatusandsurvivalinoropharyngealsquamouscellcarcinoma
AT lakshmiputtagunta egfrasabiomarkerofsmokingstatusandsurvivalinoropharyngealsquamouscellcarcinoma
AT danielaoconnell egfrasabiomarkerofsmokingstatusandsurvivalinoropharyngealsquamouscellcarcinoma
AT jeffreyharris egfrasabiomarkerofsmokingstatusandsurvivalinoropharyngealsquamouscellcarcinoma
AT hadiseikaly egfrasabiomarkerofsmokingstatusandsurvivalinoropharyngealsquamouscellcarcinoma
AT vincentlbiron egfrasabiomarkerofsmokingstatusandsurvivalinoropharyngealsquamouscellcarcinoma